ID   GBRG2_RAT               Reviewed;         466 AA.
AC   P18508;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-OCT-2024, entry version 191.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit gamma-2 {ECO:0000250|UniProtKB:P18507};
DE   AltName: Full=GABA(A) receptor subunit gamma-2 {ECO:0000250|UniProtKB:P18507};
DE            Short=GABAAR subunit gamma-2 {ECO:0000303|PubMed:28279354};
DE   Flags: Precursor;
GN   Name=Gabrg2 {ECO:0000312|RGD:61966};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, TRANSPORTER ACTIVITY,
RP   SUBCELLULAR LOCATION, SUBUNIT, AND ACTIVITY REGULATION.
RC   TISSUE=Brain;
RX   PubMed=2561970; DOI=10.1016/0896-6273(89)90257-2;
RA   Shivers B.D., Killisch I., Sprengel R., Sontheimer H., Koehler M.,
RA   Schofield P.R., Seeburg P.H.;
RT   "Two novel GABAA receptor subunits exist in distinct neuronal
RT   subpopulations.";
RL   Neuron 3:327-337(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2165521; DOI=10.1523/jneurosci.10-07-02330.1990;
RA   Malherbe P., Sigel E., Baur R., Persohn E., Richards J.G., Mohler H.;
RT   "Functional characteristics and sites of gene expression of the alpha 1,
RT   beta 1, gamma 2-isoform of the rat GABAA receptor.";
RL   J. Neurosci. 10:2330-2337(1990).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9464994; DOI=10.1523/jneurosci.18-05-01693.1998;
RA   Nusser Z., Sieghart W., Somogyi P.;
RT   "Segregation of different GABAA receptors to synaptic and extrasynaptic
RT   membranes of cerebellar granule cells.";
RL   J. Neurosci. 18:1693-1703(1998).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=17003036; DOI=10.1074/jbc.m606895200;
RA   Jin N., Kolliputi N., Gou D., Weng T., Liu L.;
RT   "A novel function of ionotropic gamma-aminobutyric acid receptors involving
RT   alveolar fluid homeostasis.";
RL   J. Biol. Chem. 281:36012-36020(2006).
RN   [5]
RP   INTERACTION WITH KIF21B, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25172774; DOI=10.1016/j.ejcb.2014.07.007;
RA   Labonte D., Thies E., Kneussel M.;
RT   "The kinesin KIF21B participates in the cell surface delivery of gamma2
RT   subunit-containing GABAA receptors.";
RL   Eur. J. Cell Biol. 93:338-346(2014).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A COMPLEX WITH
RP   NLGN2; LHFPL4; GABRA1; GABRB2 AND GABRB3.
RX   PubMed=28279354; DOI=10.1016/j.neuron.2017.02.023;
RA   Yamasaki T., Hoyos-Ramirez E., Martenson J.S., Morimoto-Tomita M.,
RA   Tomita S.;
RT   "GARLH family proteins stabilize GABAA receptors at synapses.";
RL   Neuron 93:1138-1152(2017).
RN   [7] {ECO:0007744|PDB:6DW0, ECO:0007744|PDB:6DW1}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS), FUNCTION, SUBUNIT,
RP   INTERACTION WITH GABRA1 AND GABRB1, AND DISULFIDE BOND.
RX   PubMed=30044221; DOI=10.7554/elife.39383;
RA   Phulera S., Zhu H., Yu J., Claxton D.P., Yoder N., Yoshioka C., Gouaux E.;
RT   "Cryo-EM structure of the benzodiazepine-sensitive alpha1beta1gamma2S tri-
RT   heteromeric GABAA receptor in complex with GABA.";
RL   Elife 7:0-0(2018).
CC   -!- FUNCTION: Gamma subunit of the heteropentameric ligand-gated chloride
CC       channel gated by gamma-aminobutyric acid (GABA), a major inhibitory
CC       neurotransmitter in the brain (PubMed:2561970, PubMed:30044221). GABA-
CC       gated chloride channels, also named GABA(A) receptors (GABAAR), consist
CC       of five subunits arranged around a central pore and contain GABA active
CC       binding site(s) located at the alpha and beta subunit interface(s)
CC       (PubMed:30044221). When activated by GABA, GABAARs selectively allow
CC       the flow of chloride anions across the cell membrane down their
CC       electrochemical gradient (PubMed:2561970, PubMed:30044221). Gamma-
CC       2/GABRG2-containing GABAARs are found at both synaptic and
CC       extrasynaptic sites (PubMed:9464994). Chloride influx into the
CC       postsynaptic neuron following GABAAR opening decreases the neuron
CC       ability to generate a new action potential, thereby reducing nerve
CC       transmission (By similarity). GABAARs containing alpha-1 and beta-2 or
CC       -3 subunits exhibit synaptogenic activity; the gamma-2 subunit being
CC       necessary but not sufficient to induce rapid synaptic contacts
CC       formation (By similarity). Extrasynaptic gamma-2-containing receptors
CC       contribute to the tonic GABAergic inhibition (PubMed:9464994). GABAARs
CC       function also as histamine receptor where histamine binds at the
CC       interface of two neighboring beta subunits and potentiates GABA
CC       response in a gamma-2 subunit-controlled manner (By similarity).
CC       {ECO:0000250|UniProtKB:P08219, ECO:0000250|UniProtKB:P18507,
CC       ECO:0000250|UniProtKB:P22723, ECO:0000269|PubMed:2561970,
CC       ECO:0000269|PubMed:30044221, ECO:0000269|PubMed:9464994}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:2561970};
CC   -!- ACTIVITY REGULATION: Allosterically activated by benzodiazepines (By
CC       similarity). Activated by pentobarbital (PubMed:2561970). Inhibited by
CC       the antagonist bicuculline (PubMed:2561970). Inhibited by zinc ions (By
CC       similarity). Potentiated by histamine (By similarity).
CC       {ECO:0000250|UniProtKB:P18507, ECO:0000250|UniProtKB:P22723,
CC       ECO:0000269|PubMed:2561970}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha (GABRA1-6),
CC       beta (GABRB1-3), gamma (GABRG1-3), delta (GABRD), epsilon (GABRE), rho
CC       (GABRR1-3), pi (GABRP) and theta (GABRQ) chains, each subunit
CC       exhibiting distinct physiological and pharmacological properties
CC       (PubMed:2561970, PubMed:30044221). Interacts with GABARAP (By
CC       similarity). Interacts with KIF21B (PubMed:25172774). Identified in a
CC       complex of 720 kDa composed of LHFPL4, NLGN2, GABRA1, GABRB2, GABRG2
CC       and GABRB3 (PubMed:28279354). Interacts with LHFPL4 (By similarity).
CC       Interacts with SHISA7; interaction leads to the regulation of GABA(A)
CC       receptor trafficking, channel deactivation kinetics and pharmacology
CC       (By similarity). {ECO:0000250|UniProtKB:P18507,
CC       ECO:0000250|UniProtKB:P22723, ECO:0000269|PubMed:25172774,
CC       ECO:0000269|PubMed:2561970, ECO:0000269|PubMed:28279354,
CC       ECO:0000269|PubMed:30044221}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000269|PubMed:2561970, ECO:0000269|PubMed:9464994}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:P18507}. Cell membrane
CC       {ECO:0000269|PubMed:2561970, ECO:0000269|PubMed:9464994}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:P18507}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:P22723}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:25172774}. Note=The gamma-2 subunits are present in
CC       Golgi synapses and on the extrasynaptic membranes (when associated with
CC       alpha-1/6 and beta-2/3 subunits), and in some of the mossy fiber to
CC       granule cell synapses (when associated with alpha-6 and beta-2/3
CC       subunits). Present in GABAergic and glutamatergic synapses on granule
CC       cells. {ECO:0000269|PubMed:9464994}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain (at protein level). Expressed in
CC       lungs, in alveolar epithelium (PubMed:17003036).
CC       {ECO:0000269|PubMed:17003036, ECO:0000269|PubMed:25172774,
CC       ECO:0000269|PubMed:9464994}.
CC   -!- DOMAIN: The extracellular domain contributes to synaptic contact
CC       formation. {ECO:0000250|UniProtKB:P22723}.
CC   -!- DOMAIN: GABAARs subunits share a common topological structure: a
CC       peptide sequence made up of a long extracellular N-terminal, four
CC       transmembrane domains, intracellular or cytoplasmic domain located
CC       between the third and the fourth transmembrane domains.
CC       {ECO:0000250|UniProtKB:P18507}.
CC   -!- PTM: Palmitoylated by ZDHHC3/GODZ; required for the accumulation of
CC       GABA(A) receptors at the postsynaptic membrane of inhibitory GABAergic
CC       synapses. {ECO:0000250|UniProtKB:P22723}.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:P22723}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily. GABRG2 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L08497; AAC42036.1; -; Genomic_DNA.
DR   PIR; JQ0077; JQ0077.
DR   RefSeq; NP_899156.1; NM_183327.1.
DR   PDB; 2PR9; X-ray; 2.51 A; P=400-409.
DR   PDB; 6DW0; EM; 3.80 A; D=1-466.
DR   PDB; 6DW1; EM; 3.10 A; D=1-466.
DR   PDBsum; 2PR9; -.
DR   PDBsum; 6DW0; -.
DR   PDBsum; 6DW1; -.
DR   AlphaFoldDB; P18508; -.
DR   EMDB; EMD-8922; -.
DR   EMDB; EMD-8923; -.
DR   SMR; P18508; -.
DR   BioGRID; 248326; 2.
DR   ComplexPortal; CPX-250; GABA-A receptor, alpha1-beta2-gamma2.
DR   ComplexPortal; CPX-405; GABA-A receptor, alpha6-beta3-gamma2.
DR   ComplexPortal; CPX-409; GABA-A receptor, alpha3-beta3-gamma2.
DR   ComplexPortal; CPX-410; GABA-A receptor, alpha1-beta3-gamma2.
DR   ComplexPortal; CPX-411; GABA-A receptor, alpha5-beta3-gamma2.
DR   ComplexPortal; CPX-412; GABA-A receptor, alpha2-beta3-gamma2.
DR   CORUM; P18508; -.
DR   IntAct; P18508; 3.
DR   MINT; P18508; -.
DR   STRING; 10116.ENSRNOP00000072234; -.
DR   BindingDB; P18508; -.
DR   ChEMBL; CHEMBL2095167; -.
DR   ChEMBL; CHEMBL2111327; -.
DR   ChEMBL; CHEMBL2111343; -.
DR   ChEMBL; CHEMBL2111365; -.
DR   ChEMBL; CHEMBL2111374; -.
DR   ChEMBL; CHEMBL3883322; -.
DR   ChEMBL; CHEMBL4296047; -.
DR   ChEMBL; CHEMBL4296048; -.
DR   ChEMBL; CHEMBL4296051; -.
DR   ChEMBL; CHEMBL4296054; -.
DR   ChEMBL; CHEMBL4296062; -.
DR   ChEMBL; CHEMBL5291947; -.
DR   ChEMBL; CHEMBL5291950; -.
DR   DrugCentral; P18508; -.
DR   GlyCosmos; P18508; 3 sites, No reported glycans.
DR   GlyGen; P18508; 3 sites.
DR   iPTMnet; P18508; -.
DR   SwissPalm; P18508; -.
DR   PaxDb; 10116-ENSRNOP00000004619; -.
DR   ABCD; P18508; 3 sequenced antibodies.
DR   Ensembl; ENSRNOT00000082445.2; ENSRNOP00000072234.2; ENSRNOG00000003241.7.
DR   Ensembl; ENSRNOT00055004755; ENSRNOP00055003524; ENSRNOG00055003048.
DR   Ensembl; ENSRNOT00060034154; ENSRNOP00060027994; ENSRNOG00060019761.
DR   Ensembl; ENSRNOT00065001774; ENSRNOP00065001233; ENSRNOG00065001340.
DR   GeneID; 29709; -.
DR   KEGG; rno:29709; -.
DR   UCSC; RGD:61966; rat.
DR   AGR; RGD:61966; -.
DR   CTD; 2566; -.
DR   RGD; 61966; Gabrg2.
DR   eggNOG; KOG3642; Eukaryota.
DR   HOGENOM; CLU_010920_2_0_1; -.
DR   InParanoid; P18508; -.
DR   OrthoDB; 4265336at2759; -.
DR   Reactome; R-RNO-977443; GABA receptor activation.
DR   EvolutionaryTrace; P18508; -.
DR   PRO; PR:P18508; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003241; Expressed in frontal cortex and 2 other cell types or tissues.
DR   ExpressionAtlas; P18508; baseline and differential.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032590; C:dendrite membrane; IDA:BHF-UCL.
DR   GO; GO:1902710; C:GABA receptor complex; IDA:BHF-UCL.
DR   GO; GO:1902711; C:GABA-A receptor complex; ISS:UniProtKB.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0060077; C:inhibitory synapse; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IBA:GO_Central.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:1902495; C:transmembrane transporter complex; IBA:GO_Central.
DR   GO; GO:0005254; F:chloride channel activity; IDA:RGD.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:RGD.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; ISS:UniProtKB.
DR   GO; GO:0005237; F:inhibitory extracellular ligand-gated monoatomic ion channel activity; TAS:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0030534; P:adult behavior; ISO:RGD.
DR   GO; GO:0071420; P:cellular response to histamine; ISS:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; IDA:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:RGD.
DR   GO; GO:0006821; P:chloride transport; IDA:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; ISO:RGD.
DR   GO; GO:1904862; P:inhibitory synapse assembly; ISS:UniProtKB.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; IBA:GO_Central.
DR   GO; GO:0072347; P:response to anesthetic; IMP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; IDA:BHF-UCL.
DR   CDD; cd19000; LGIC_ECD_GABAAR_G; 1.
DR   CDD; cd19054; LGIC_TM_GABAAR_gamma; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1.
DR   IDEAL; IID50125; -.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR005439; GABBAg2_rcpt.
DR   InterPro; IPR005437; GABRG-1/4.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF498; GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT GAMMA-2; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01620; GABAARGAMMA.
DR   PRINTS; PR01622; GABAARGAMMA2.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Chloride; Chloride channel;
KW   Cytoplasmic vesicle; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Lipoprotein; Membrane; Palmitate;
KW   Postsynaptic cell membrane; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..38
FT                   /evidence="ECO:0000255"
FT   CHAIN           39..466
FT                   /note="Gamma-aminobutyric acid receptor subunit gamma-2"
FT                   /id="PRO_0000000479"
FT   TOPO_DOM        39..274
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        275..295
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P18507"
FT   TOPO_DOM        296..301
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        302..321
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P18507"
FT   TOPO_DOM        322..333
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        334..358
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P18507"
FT   TOPO_DOM        359..442
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        443..463
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P18507"
FT   TOPO_DOM        464..466
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   CARBOHYD        51
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        128
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        246
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        189..203
FT                   /evidence="ECO:0000269|PubMed:30044221,
FT                   ECO:0007744|PDB:6DW0, ECO:0007744|PDB:6DW1"
FT   CONFLICT        22
FT                   /note="M -> I (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   HELIX           64..70
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   TURN            71..75
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          82..87
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          90..103
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          106..121
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   HELIX           123..125
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          129..136
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          166..172
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          175..188
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          195..198
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   TURN            214..216
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          218..225
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          243..246
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          249..252
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          257..260
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          263..267
FT                   /evidence="ECO:0007829|PDB:6DW1"
SQ   SEQUENCE   466 AA;  54077 MW;  3C60B66E0D23072F CRC64;
     MSSPNTWSTG STVYSPVFSQ KMTLWILLLL SLYPGFTSQK SDDDYEDYAS NKTWVLTPKV
     PEGDVTVILN NLLEGYDNKL RPDIGVKPTL IHTDMYVNSI GPVNAINMEY TIDIFFAQTW
     YDRRLKFNST IKVLRLNSNM VGKIWIPDTF FRNSKKADAH WITTPNRMLR IWNDGRVLYT
     LRLTIDAECQ LQLHNFPMDE HSCPLEFSSY GYPREEIVYQ WKRSSVEVGD TRSWRLYQFS
     FVGLRNTTEV VKTTSGDYVV MSVYFDLSRR MGYFTIQTYI PCTLIVVLSW VSFWINKDAV
     PARTSLGITT VLTMTTLSTI ARKSLPKVSY VTAMDLFVSV CFIFVFSALV EYGTLHYFVS
     NRKPSKDKDK KKKNPAPTID IRPRSATIQM NNATHLQERD EEYGYECLDG KDCASFFCCF
     EDCRTGAWRH GRIHIRIAKM DSYARIFFPT AFCLFNLVYW VSYLYL
//
